Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Mol Cancer Ther. 2013 Feb 26;12(5):10.1158/1535-7163.MCT-12-1130. doi: 10.1158/1535-7163.MCT-12-1130

Table 2.

DTP COMPARE Analysis1: Mechanism of Action of RPC Δ-32+ (NSC 747949)

Class Drug Correlation
Antimitotic Agent Paclitaxel 0.91
Vincristine 0.55
Echinomycin 0.49
RNA/DNA Antimetabolite Pyrazofurin 0.67
5-FUDR 0.53
5-fluorouracil 0.53
Ftoafur 0.52
Thioguanine 0.41
Alkylating Agent Cyclodisone 0.62
Piperazine alkylator 0.57
Mitomycin C 0.52
Porfiromycin 0.51
CCNU 0.50
Cisplatin 0.47
Chlorambucil 0.43
Thio-tepa 0.43
Tetraplatin 0.42
Chlorozotocin 0.40
Topo II "N, N-dibenzyldaunomycin” 0.52
1

The DTP Compare Analysis uses cytotoxicity data for the test-drug across the NCI-60 spectrum of cell lines to determine is a correlation coefficient of measurement of the similarity in cytotoxic mechanism between the test subject drug, and known cytotoxic drugs with known mechanisms of action. The correlation coefficient ranging from 0 to 1 reflects the degree of similarity. Thus the above findings indicate maximum similarity of mechanism to paclitaxel and significant similarity to several drugs across the antimetabolite and alkylating agent class.